Casi Pharmaceuticals Stock News

CASI Pharmaceuticals Inc. (NASDAQ:CASI) price closed higher on Wednesday, November 17, jumping 2.08% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy

Equities research analysts expect that CASI Pharmaceuticals, Inc. (NASDAQ:CASI) will announce earnings per share of ($0.06) for the current fiscal quarter, Zacks reports. Two analysts have made estimates for CASI Pharmaceuticals’ earnings, with the highest EPS estimate coming in at ($0.05) and the lowest estimate coming in at ($0.06). CASI Pharmaceuticals reported earnings per share […]

CASI Pharmaceuticals (NASDAQ:CASI) posted its earnings results on Thursday. The biotechnology company reported ($0.07) earnings per share for the quarter, missing the Thomson Reuters consensus estimate of ($0.06) by ($0.01), MarketWatch Earnings reports. CASI Pharmaceuticals had a negative net margin of 236.69% and a negative return on equity of 56.52%. During the same period in []

CASI Pharmaceuticals, Inc. (CASI) CEO Wei-Wu He on Q3 2021 Results - Earnings Call Transcript

CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Friday, 2021-11-12. Here's what investors need to know before the announcement.

CASI Pharmaceuticals, Inc. (CASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CASI Pharma (CASI) has been struggling lately, but the selling pressure may be coming to an end soon.

ROCKVILLE, Md. and BEIJING, Sept.

Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.

Are these penny stocks worth the risk? The post Trending Penny Stocks To Buy For Under $3 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

The shares of CASI Pharmaceuticals, Inc. (Nasdaq: CASI) increased by over 16% pre-market. This is why it happened.

CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q2 2021 Results - Earnings Call Transcript

ROCKVILLE, Md. and BEIJING, Aug. 10, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutic

CASI Pharmaceuticals, Inc. (CASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ROCKVILLE, Md. and BEIJING, June 10, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics